Company intelligence / Profile preview
pHion Therapeutics
Belfast, Northern Ireland, United Kingdomphiontx.co.uk ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Pre-clinical stage vaccines with lead PTX_V1 completing toxicology and planning Phase I/IIA trials for HPV-driven cancers; company entered administration in 2024.[1][2][4][6][7]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- mRNA-based drugsPeptide
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
invoX Pharma
Beyond the preview
Go deeper on pHion Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pHion Therapeutics.